Brown, Lisle/Cummings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $166K | Sell |
1,499
-125
| -8% | -$13.9K | 0.04% | 230 |
|
2025
Q1 | $182K | Buy |
1,624
+49
| +3% | +$5.49K | 0.05% | 208 |
|
2024
Q4 | $145K | Sell |
1,575
-500
| -24% | -$46.2K | 0.04% | 234 |
|
2024
Q3 | $174K | Sell |
2,075
-766
| -27% | -$64.2K | 0.05% | 219 |
|
2024
Q2 | $195K | Buy |
2,841
+1
| +0% | +$69 | 0.06% | 202 |
|
2024
Q1 | $208K | Sell |
2,840
-224
| -7% | -$16.4K | 0.07% | 193 |
|
2023
Q4 | $248K | Sell |
3,064
-149
| -5% | -$12.1K | 0.09% | 178 |
|
2023
Q3 | $241K | Buy |
3,213
+77
| +2% | +$5.77K | 0.11% | 166 |
|
2023
Q2 | $242K | Sell |
3,136
-1,349
| -30% | -$104K | 0.11% | 165 |
|
2023
Q1 | $372K | Sell |
4,485
-2,019
| -31% | -$168K | 0.19% | 122 |
|
2022
Q4 | $558K | Buy |
6,504
+181
| +3% | +$15.5K | 0.3% | 86 |
|
2022
Q3 | $390K | Sell |
6,323
-116
| -2% | -$7.16K | 0.23% | 105 |
|
2022
Q2 | $398K | Sell |
6,439
-417
| -6% | -$25.8K | 0.22% | 106 |
|
2022
Q1 | $408K | Buy |
6,856
+1,065
| +18% | +$63.3K | 0.2% | 114 |
|
2021
Q4 | $420K | Buy |
+5,791
| New | +$420K | 0.21% | 109 |
|